Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8806639-01 48 Well
Rat WNT3A (Wingless Type MMTV Integration Site Family, Member 3A) ELISA Kit
Sign In for Pricing
View Details 
MBS8806639-02 96 Well
Rat WNT3A (Wingless Type MMTV Integration Site Family, Member 3A) ELISA Kit
Sign In for Pricing
View Details 
MBS8806639-03 5x 96 Well
Rat WNT3A (Wingless Type MMTV Integration Site Family, Member 3A) ELISA Kit
Sign In for Pricing
View Details 
MBS8806639-04 10x 96 Well
Rat WNT3A (Wingless Type MMTV Integration Site Family, Member 3A) ELISA Kit
Sign In for Pricing
View Details MBS1124184-01 0.02 mg (E-Coli)
Recombinant Francisella tularensis subsp. novicida Lipid-A-disaccharide synthase (lpxB)
Sign In for Pricing
View Details